Finding consensus on the physiotherapy management of asymptomatic infants with cystic fibrosis
1Cystic Fibrosis Unit, Great Ormond Street Hospital for Children, London, UK. prasaa@gosh.nhs.uk
Insights
Expert consensus on physiotherapy for babies with cystic fibrosis (CF) found agreement on most management aspects. However, routine daily chest physiotherapy for asymptomatic infants remains debated, allowing flexible approaches.
Area of Science:
- Pediatric Pulmonology
- Respiratory Physiotherapy
- Cystic Fibrosis Management
Background:
- Neonatal screening identifies babies with cystic fibrosis (CF) who often lack early respiratory symptoms.
- The necessity of traditional daily chest physiotherapy for these asymptomatic infants is debated internationally.
- Current evidence is lacking, and practical challenges prevent large-scale trials in the UK.
Purpose of the Study:
- To establish expert consensus on physiotherapy management for infants diagnosed with CF via neonatal screening.
- To address the uncertainty surrounding the role of chest physiotherapy in asymptomatic CF infants.
Main Methods:
- A Delphi consensus method was employed, involving senior pediatric physiotherapists across the UK.
- Experts reviewed and voted on 16 statements concerning physiotherapy for asymptomatic infants with CF.
Main Results:
- High consensus (15/16 statements) was achieved among 25 participating physiotherapists.
- Consensus failed on whether to routinely initiate daily chest physiotherapy for asymptomatic infants.
- An amended statement allows flexibility in treatment initiation based on clinical judgment.
Conclusions:
- Senior UK physiotherapists largely agree on managing infants with CF.
- There is no consensus on the routine need for daily chest physiotherapy in asymptomatic CF infants.
- The findings will inform national clinical guidelines for CF physiotherapy, allowing adapted practices.
Background:
Babies with cystic fibrosis diagnosed by neonatal screening often display no overt signs of respiratory disease. The role of traditional routine daily chest physiotherapy in this particular group of babies is unclear and has generated considerable international debate. There is currently no evidence addressing this issue and present circumstances preclude a rigorous trial in the UK. This study aimed to provide expert consensus regarding the physiotherapy management of asymptomatic infants with CF.
Method:
A Delphi consensus method was used to gather and refine expert opinions of senior paediatric physiotherapists in the UK. Agreement was sought on 16 statements reflecting aspects of physiotherapy management in 'asymptomatic' babies with cystic fibrosis.
Results:
Twenty-five senior paediatric physiotherapists from Specialist CF Centres throughout the UK participated in the study. Consensus was high amongst the respondents for 15 of the 16 statements. One statement failed to reach consensus. This related to the question of not routinely initiating a daily chest physiotherapy regimen in apparently healthy babies. Due to the lack of consensus an amendment to this statement was made, to allow a more flexible approach, where physiotherapists would not be obliged to initiate routine daily treatment in asymptomatic babies with CF, if they felt other another approach was justified.
Conclusion:
There was high consensus of opinion amongst senior physiotherapists in the UK on most aspects of the physiotherapy management of babies with CF. Consensus could not be achieved on whether routine daily chest physiotherapy is necessary in 'asymptomatic' babies. An agreed amendment to the original statement allows professionals to modify or change traditional practice with the sanction of their senior colleagues. The results of this process will be used by the Association of Chartered Physiotherapists in Cystic Fibrosis to form the basis of national clinical guidelines.
More Related Videos
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chest Physiotherapy
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...


